Celadon Pharmaceuticals Hits Harvest Milestone

Celadon Pharmaceuticals Hits Harvest Milestone

Celadon Pharmaceuticals PLC (GB:CEL) has released an update.

Celadon Pharmaceuticals PLC, a pioneering UK-based company, has announced the on-schedule completion of its eighth cannabis harvest of the year, with plans to achieve a total of 15 harvests in 2024. The company’s custom indoor hydroponic facility supports this high-frequency harvest schedule, enhancing yields and meeting their £1.4 million annual sales contracts with two UK pharmaceutical companies. Celadon is addressing UK supply issues by providing a steady supply of pharmaceutical-grade cannabis, positioning itself as a key player in the domestic market.

For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App